Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS

AIDS. 2016 May 15;30(8):1163-74. doi: 10.1097/QAD.0000000000001079.

Abstract

Objective: There is an urgent need for the development of HIV-1 genome eradication strategies that lead to a permanent cure for HIV-1/AIDS. We previously reported that four guide RNAs (gRNAs) targeting HIV-1 long terminal repeats (LTR) effectively eradicated the entire HIV-1 genome. In this study, we sought to identify the best gRNAs targeting HIV-1 LTR and viral structural region and optimize gRNA pairing that can efficiently eradicate the HIV-1 genome.

Design: Highly specific gRNAs were designed using bioinformatics tools, and their capacity of guiding CRISPR-associated system 9 to cleave HIV-1 proviral DNA was evaluated using high-throughput HIV-1 luciferase reporter assay and rapid Direct-PCR genotyping.

Methods: The target seed sequences for each gRNA were cloned into lentiviral vectors. HEK293T cells were cotransfected with a pEcoHIV-NL4-3-firefly-luciferase reporter vector (1 : 20) over lentiviral vectors carrying CRISPR-associated system 9 and single gRNA or various combinations of gRNAs. The EcoHIV DNA cleaving efficiency was evaluated by Direct-PCR genotyping, and the EcoHIV transcription/replication activity was examined by a luciferase reporter assay.

Results: Most of the designed gRNAs are effective to eliminate the predicted HIV-1 genome sequence between the selected two target sites. This is evidenced by the presence of PCR genotypic deletion/insertion and the decrease of luciferase reporter activity. In particular, a combination of viral structural gRNAs with LTR gRNAs provided a higher efficiency of genome eradication and an easier approach for PCR genotyping.

Conclusion: Our screening strategy can specifically and effectively identify gRNAs targeting HIV-1 LTR and structural region to excise proviral HIV-1 from the host genome.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acquired Immunodeficiency Syndrome / therapy
  • Acquired Immunodeficiency Syndrome / virology*
  • Anti-HIV Agents / metabolism*
  • Biological Products / metabolism*
  • Computational Biology
  • Gene Expression Regulation, Viral*
  • Genes, Reporter
  • Genetic Testing*
  • Genome, Viral
  • Genotyping Techniques
  • HEK293 Cells
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Humans
  • Luciferases / analysis
  • Luciferases / genetics
  • Polymerase Chain Reaction
  • Proviruses / drug effects
  • Proviruses / genetics
  • RNA, Guide, CRISPR-Cas Systems / genetics
  • RNA, Guide, CRISPR-Cas Systems / metabolism*
  • Recombination, Genetic
  • Virus Latency / drug effects

Substances

  • Anti-HIV Agents
  • Biological Products
  • RNA, Guide, CRISPR-Cas Systems
  • Luciferases